SERA Earnings

SERA reported its earnings on 2026-05-06, showcasing a revenue of 14.00K against an estimate of 150.00K, resulting in a -90.67% surprise. The EPS was -0.17, surpassing the expected -0.16 by -6.25%. The stock experienced a 6.08% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following SERA's earnings announcement on 2026-05-06, the stock price moved by 6.08% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, SERA's stock price tends to shift by an average of 8.69% in the 10 days leading up to earnings and -5.15% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate SERA's annual revenue to reach 80.00K, while the EPS is projected at -0.19. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SERA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SERA's stock price typically moves by 8.69% in the 10 days before its earnings and -5.15% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.19 and revenue of 80.00K.

The earnings call reveals several concerns: declining revenue, increased operating expenses, and a slight rise in net loss, indicating financial struggles. The shift from R&D to commercial efforts could hinder future innovation. Additionally, challenges in payer engagement and European market entry pose risks. While management remains optimistic about partnerships and Medicaid coverage, the lack of specific metrics and timelines, coupled with potential delays, adds uncertainty. These factors suggest a negative sentiment, likely impacting the stock price negatively in the short term.